Mn Services Vermogensbeheer Boosts Stake in Intuitive Surgical

The institutional investor increased its holdings in the medical equipment provider by 1.9% during the fourth quarter.

Mar. 31, 2026 at 9:39am

A close-up, high-contrast image of the intricate mechanical components and precision engineering of an Intuitive Surgical robotic arm, conveying the advanced technology behind the company's medical devices.Mn Services Vermogensbeheer's increased stake in Intuitive Surgical reflects the institutional investor's confidence in the medical technology company's advanced robotic surgical systems.Sunnyvale Today

Mn Services Vermogensbeheer B.V., an institutional investor, raised its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.9% during the fourth quarter, according to the company's latest Form 13F filing with the Securities & Exchange Commission. The investor now owns 138,778 shares of the medical equipment provider's stock, valued at $78,598,000.

Why it matters

Intuitive Surgical is a leading provider of robotic-assisted surgical systems, and the company's performance is closely watched by investors. Mn Services Vermogensbeheer's increased stake suggests confidence in the company's long-term growth prospects.

The details

According to the filing, Mn Services Vermogensbeheer B.V. acquired an additional 2,578 shares of Intuitive Surgical during the fourth quarter, bringing its total holdings to 138,778 shares. The institutional investor's stake in the company is now valued at $78,598,000.

  • Mn Services Vermogensbeheer B.V. filed the 13F report for the fourth quarter of 2025.

The players

Mn Services Vermogensbeheer B.V.

An institutional investor that manages assets on behalf of clients.

Intuitive Surgical, Inc.

A medical technology company that develops and manufactures robotic-assisted surgical systems, including the da Vinci Surgical System.

Got photos? Submit your photos here. ›

The takeaway

Mn Services Vermogensbeheer's increased stake in Intuitive Surgical suggests the institutional investor sees long-term growth potential in the medical technology company, which is a leader in the field of robotic-assisted surgery.